Globe Newswire
KING OF PRUSSIA, Pa., May 08, 2024 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ: VERX) (“Vertex” or the “Company”), a leading global provider of indirect tax solutions, today announced financial results for its first quarter ended March 31, 2024.
“The year is off to a solid start, and I am very pleased with our financial performance in the first quarter,” stated David DeStefano, Vertex’s President, Chief Executive Officer and Chairperson of the Board.... (continue reading...)
Olema will host an investor conference call at 8:00 a.m. ET on May 15, 2024
SAN FRANCISCO, May 08, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology,” Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted therapies for women’s cancers, today announced that it will present new clinical data from the Company’s ongoing Phase 1b/2 clinical study of... (continue reading...)
● Acquired Canada-based uranium property
● Closed non-brokered private placement
Vancouver, British Columbia, May 08, 2024 (GLOBE NEWSWIRE) -- MegaWatt Lithium and Battery Metals Corp. (CSE:MEGA) (FSE: WR20) (OTCQB: WALRF) (the "Company", "MegaWatt Metals" or “MegaWatt”) is pleased to provide a corporate update regarding the Company’s recent developments and upcoming... (continue reading...)
CALGARY, Alberta, May 08, 2024 (GLOBE NEWSWIRE) -- Black Diamond Group Limited (TSX: BDI) (“Black Diamond” or the “Company”) announces that it has obtained approval of the Toronto Stock Exchange (the “TSX”) to renew its normal course issuer bid (the “NCIB”) with respect to its common shares (the “Common Shares”). The NCIB will commence on May 10, 2024, and will terminate on the earlier of May 9, 2025, the date on which the Company has purchased the... (continue reading...)
Record First Quarter Revenue Reflecting 4% Growth and 12% Organic GrowthGAAP net income up 229% to $49M and record adjusted EBITDA up 15% to $218MGAAP EPS up 263% to $1.09 and non-GAAP EPS up 20% to $1.52TTM GAAP Net Cash from Operations up 56% to $800M: non-GAAP Free Cash Flow up 61% to $363M
RICHMOND, Va., May 08, 2024 (GLOBE NEWSWIRE) -- The Brink’s Company (NYSE: BCO), a leading global provider of cash and valuables management, digital retail solutions (DRS),... (continue reading...)
More Globe Newswire
View Older Stories-
Sprott Announces First Quarter 2024 Results
-
StateHouse Announces Receipt of Failure to File Cease Trade Order
-
Brink's Announces Strong First-Quarter Results and Affirms Full Year Guidance
-
CanLift Celebrates 15 Years of Business in Ontario
-
SpringWorks Therapeutics to Participate in the BofA Securities 2024 Health Care Conference
-
Aura Biosciences to Participate in Upcoming Investor Conferences
-
Kamada Reports Strong First Quarter 2024 Financial Results with Year-Over-Year Top-Line Growth of 23% and a 96% Increase in Profitability; Raises Full-Year Financial Guidance
-
Cingulate Reports First Quarter 2024 Financial Results and Provides Clinical and Business Update
-
Brunswick Exploration Drills 93.45 Meters at 1.55% Li2O at MR-6
-
Standard Uranium Begins Inaugural Drill Program at Canary Project, Eastern Athabasca Basin
-
Microbix Schedules Release of Results for Q2 Fiscal 2024
-
Hain Celestial Reports Fiscal Third Quarter 2024 Financial Results
-
Amicus Therapeutics to Present at the Bank of America 2024 Health Care Conference
-
Bio-Path Holdings to Announce First Quarter 2024 Financial Results on May 15, 2024
-
R1 RCM Reports First Quarter 2024 Results
-
EyePoint Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Corporate Developments
-
Dragonfly Energy Named Business of the Year at Nevada Business Awards
-
Cartesian Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
-
Sage launches two new integrated suites in Canada and the UK to help Accountants and Small Businesses drive growth
-
Avadel Pharmaceuticals Provides Corporate Update and Reports First Quarter 2024 Financial Results
-
Arbor Biotechnologies Announces Acquisition of Serendipity
-
Beasley Broadcast Group Reports First Quarter Revenue of $54.4 Million
-
PolyPid Provides Corporate Update and Reports First Quarter 2024 Financial Results
-
Zevra Therapeutics Reports First Quarter 2024 Financial Results and Corporate Updates
-
GDS to Report First Quarter 2024 Financial Results Before the Open of the U.S. Market on May 22, 2024
-
OKYO Pharma Announces Participation in May 2024 Investor Conferences
-
PolyPid Provides Corporate Update and Reports First Quarter 2024 Financial Results
-
Inception Growth Acquisition Limited Announces Additional Contribution to Trust Account to Extend Business Combination Period
-
Chemomab Therapeutics Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule
-
Village Farms International Reports Strong Q1/24 Results
-
Multi Ways Holdings Expands Fleet with the Acquisition of 16 New Crawler Cranes
-
Axsome Therapeutics to Present at Upcoming Investor Conferences
-
Akero Therapeutics to Present at the BofA Securities 2024 Health Care Conference
-
Stella-Jones Announces First Quarter Results
-
Mayfair Gold Provides Update on Fenn-Gib Gold Project
-
Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2024 Financial Results
-
EcoSafi announces the first issuance of carbon credits in Africa under high-integrity Gold Standard MECD methodology
-
Gen II Announces The Rebranding of its Portal to Sensr Portal
-
Editas Medicine Announces First Quarter 2024 Results and Business Updates
-
C4 Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
-
Kaltura Announces Financial Results for First Quarter 2024
-
REE Automotive Continues to Expand Full by-Wire EV Offering at ACT Expo 2024
-
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Plug
-
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ocugen
-
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Luna
-
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Innoviz
-
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Evolv
-
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Anavex
-
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Checkpoint
-
CRISPR Therapeutics Highlights ASGCT Oral Presentation and Announces New Programs Utilizing In Vivo Gene Editing Approach